Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100,000
Closed -$6.58M 31
2025
Q2
$6.58M Buy
100,000
+55,000
+122% +$3.42M 4.28% 9
2025
Q1
$2.95M Buy
+45,000
New +$3.05M 1.56% 24
2024
Q4
Sell
-100,000
Closed -$8.35M 27
2024
Q3
$8.35M Sell
100,000
-392,000
-80% -$26.1M 2.46% 18
2024
Q2
$27.2M Buy
492,000
+192,000
+64% +$10.4M 5.2% 6
2024
Q1
$20.9M Buy
300,000
+251,736
+522% +$16M 3.25% 13
2023
Q4
$2.68M Sell
48,264
-239,236
-83% -$10.8M 0.46% 31
2023
Q3
$10.3M Buy
287,500
+250,000
+667% +$8.62M 1.88% 24
2023
Q2
$1.19M Sell
37,500
-219,506
-85% -$8.39M 0.23% 37
2023
Q1
$7.92M Buy
+257,006
New +$7.8M 1.55% 24

Other funds holding ACLX

Great Point Partners's ACLX Position: Q3 2025 in Review

Great Point Partners sold out of Arcellx (ACLX) in Q3 2025, closing a stake of 100,000 shares — an estimated $6.58M sold.

Great Point Partners first reported a position in ACLX in Q1 2023 and held it in 9 quarters. The position peaked at $27.2M in Q2 2024. 209 funds tracked by Wall St. Rank hold ACLX as of Q3 2025.

  • Great Point Partners reported no remaining Arcellx position as of Q3 2025 after selling out during the quarter.
  • Great Point Partners sold 100,000 Arcellx shares in Q3 2025, an estimated $6.58M.
  • Great Point Partners first reported a position in Arcellx in Q1 2023 and held it in 9 quarters.
  • Great Point Partners's Arcellx position peaked at $27.2M in Q2 2024.
  • 209 funds tracked by Wall St. Rank held Arcellx as of Q3 2025.

Based on Great Point Partners's 13F filing for Q3 2025, filed 14 Nov 2025.